Patriot Financial Group Insurance Agency’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Patriot Financial Group Insurance Agency's REGN Position: Q3 2022 in Review
Patriot Financial Group Insurance Agency sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 23 shares — an estimated $14K sold.
Patriot Financial Group Insurance Agency first reported a position in REGN in Q4 2016 and held it in 19 quarters. The position peaked at $39K in Q3 2021. 1,081 funds tracked by Wall St. Rank hold REGN as of Q3 2022.
- Patriot Financial Group Insurance Agency reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Patriot Financial Group Insurance Agency sold 23 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $14K.
- Patriot Financial Group Insurance Agency first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 19 quarters.
- Patriot Financial Group Insurance Agency's Regeneron Pharmaceuticals position peaked at $39K in Q3 2021.
- 1,081 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.
Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.